Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk
- DOI
- 10.1161/jaha.124.040217
- Published
- 2025-08-05
- Container
- Journal of the American Heart Association
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1161/jaha.124.040217,
title = {Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk},
author = {Yihong Deng and Eric C. Polley and Jeph Herrin and Kavya S. Swarna and David M. Kent and Joseph S. Ross and Bradley A. Maron and Mindy M. Mickelson and Rozalina G. McCoy},
year = {2025},
journal = {Journal of the American Heart Association},
doi = {10.1161/jaha.124.040217},
url = {https://doi.org/10.1161/jaha.124.040217}
}RIS
TY - JOUR TI - Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk AU - Yihong Deng AU - Eric C. Polley AU - Jeph Herrin AU - Kavya S. Swarna AU - David M. Kent AU - Joseph S. Ross AU - Bradley A. Maron AU - Mindy M. Mickelson AU - Rozalina G. McCoy PY - 2025 JO - Journal of the American Heart Association DO - 10.1161/jaha.124.040217 UR - https://doi.org/10.1161/jaha.124.040217 ER -
APA
Deng, Y., Polley, E. C., Herrin, J., Swarna, K. S., Kent, D. M., Ross, J. S., Maron, B. A., Mickelson, M. M., & McCoy, R. G. (2025). Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040217
Source records
- crossref · retrieved 2026-09-26T17:50:30.653Z